FDA’s list of off-patent drugs suggests higher approvals of first generics in 2022
We usher in 2023 with the key highlights of the US Food and Drug Administration’s December 202
Top drugs and pharma companies by sales in 2020
Last
year, the pandemic impacted everyone’s life in one way or the other. It turned
the lime